Assisted suicide is when a person intentionally ends their own life using medication prescribed by a physician for that purpose. The key distinction is that the patient, not the doctor, takes the final action. In practice, this usually means a terminally ill adult receives a prescription for a lethal dose of medication and chooses when, or whether, to take it.
The topic sits at the intersection of medicine, law, and ethics, and the terminology itself is often debated. Understanding the differences between related terms, who qualifies, what the process actually looks like, and where it’s legal can help clarify a subject that’s frequently misunderstood.
Assisted Suicide, Euthanasia, and Medical Aid in Dying
These three terms describe different things, though they’re often used interchangeably in casual conversation. In assisted suicide, a physician prescribes a lethal medication, but the patient takes it themselves. In euthanasia, a physician directly administers the lethal medication. That distinction matters legally and ethically: in most places where one is permitted, the other is not.
“Medical aid in dying” is a newer term that many advocates and legislators prefer. It carries a specific meaning: a terminally ill patient takes prescribed medication to achieve a death aligned with their own values. The emphasis is on the patient already being in the process of dying from a terminal illness, not choosing death over continued life. This framing is deliberate. Supporters argue that “assisted suicide” carries stigma and inaccurately equates the decision with suicide driven by mental illness or despair, while opponents argue the newer term obscures what is fundamentally happening.
The American Medical Association uses “physician-assisted suicide” in its official ethics code and defines it as a physician providing the means or information to enable a patient to perform a life-ending act.
Who Qualifies
Every jurisdiction that permits this practice requires the same core criteria. The patient must be a mentally competent adult with a terminal illness. In the United States, that typically means a prognosis of six months or less to live, confirmed by two separate physicians, each of whom must be a licensed M.D. or D.O. in the state.
Mental capacity is a firm requirement. If either physician suspects that a mental health condition like depression may be impairing the patient’s judgment, they are required to refer the patient for a psychiatric or psychological evaluation before proceeding. In practice, though, these referrals happen rarely. The patient must also be capable of self-administering the medication, usually by drinking it from a cup or pouring it through a feeding tube. No one else can administer it for them.
Advance directives don’t count. A person cannot arrange this in advance for a future point when they might lose decision-making capacity. The request must come from someone who is currently competent and able to follow through on their own.
How the Process Works
Oregon’s Death with Dignity Act, passed in 1994, established the template that most U.S. states have since followed. The patient must make two separate oral requests to their physician, spaced at least 15 days apart. They must also submit a written request signed in the presence of two witnesses. A change to Oregon’s law in 2020 allows patients whose life expectancy is less than 15 days to skip the waiting period.
After both physicians have confirmed eligibility, the attending physician writes a prescription. The patient fills it at a pharmacy, takes the medication home, and decides independently whether and when to use it. Many people who receive prescriptions never take the medication. Oregon’s 2024 data illustrates this clearly: 607 people received prescriptions that year, but only 333 of them (55%) died from ingesting the drugs. Some died of their underlying illness before using the prescription. Others simply found comfort in having the option.
The most common underlying illness among Oregon patients was cancer (57%), followed by neurological disease (15%) and heart disease (11%).
What Patients Actually Take
The medications used have evolved over time. Early protocols required patients to crush 90 to 100 barbiturate pills, mix them into a sweet liquid, and drink the solution. Because the mixture is intensely bitter and can cause vomiting, patients take anti-nausea medication beforehand.
Later drug combinations were developed to avoid reliance on barbiturates, which became harder to obtain. These combinations typically include a sedative, a heart medication, a pain reliever, and a secondary agent. However, results have been inconsistent. In one analysis, 55% of patients given one common combination and 45% given another experienced a dying process that lasted longer than one hour. This unpredictability remains one of the practical challenges of the practice.
For euthanasia in countries where it’s legal, the process is different. A physician first administers a general anesthetic to induce unconsciousness, sometimes preceded by an anti-anxiety medication, followed by an agent that stops breathing and heart function. This physician-administered approach is generally faster and more predictable, but it is a fundamentally different legal and ethical category.
Where It’s Legal
In the United States, Oregon led the way in 1994, and several states have since passed similar laws. The specifics vary by state, but the core framework of two physicians, a waiting period, terminal diagnosis, mental competency, and self-administration remains consistent across all of them.
Globally, the landscape is more varied. Four EU countries (Belgium, Spain, Luxembourg, and the Netherlands) permit euthanasia administered by a physician. Germany, Italy, and Austria allow assisted suicide only. Several other EU nations, including France, Ireland, Portugal, and Malta, are actively working on legislation. Portugal’s parliament passed a law in 2023, but it has not taken effect due to presidential vetoes and constitutional court rulings. Canada and several Australian states also have legal frameworks, each with their own eligibility criteria and safeguards.
Every jurisdiction has developed its own approach to preventing abuse, and no two regulatory systems are identical.
The Medical Profession’s Divided Stance
The AMA officially opposes physician-assisted suicide, stating that it is “fundamentally incompatible with the physician’s role as healer” and would “pose serious societal risks.” This is not a neutral position: the organization’s ethics code explicitly articulates opposition.
At the same time, the AMA acknowledges a reality: individual physicians who, after careful moral consideration, participate in the practice where it is legal will not be considered in violation of the ethics code. This creates an unusual space where the professional organization opposes a practice but does not discipline members who engage in it lawfully. Other medical organizations, including some state medical associations, have taken neutral or supportive positions, reflecting genuine disagreement within the profession.
Safeguards Built Into the Law
The legal frameworks share a common set of protections designed to prevent coercion and misuse. These safeguards, first established in Oregon’s law and adopted in nearly every subsequent statute, include: a mental health evaluation when impaired judgment is suspected, confirmation of a terminal illness, a requirement that patients self-administer the medication, restriction to adults, confirmation of decision-making capacity (not through advance directives), a mandatory waiting period between requests, and certification by two independent physicians.
Critics argue these safeguards are insufficient, pointing out that psychiatric referrals happen infrequently and that the six-month prognosis requirement is inherently imprecise. Supporters counter that decades of data from Oregon and other states show no evidence of widespread abuse, and that the number of people who receive prescriptions but never use them suggests the system is not pushing people toward death.
Cost and Insurance Coverage
The out-of-pocket cost of the medications themselves is relatively modest compared to ongoing end-of-life care, and studies in both the U.S. and Canada have found no significant additional costs to patients beyond what they would already face with their terminal illness. In the U.S., some insurance plans cover the medications, and Medicare may cover associated physician visits.
A more contentious finding is that some insurance companies have been willing to cover aid-in-dying medications while declining to cover potentially life-extending treatments. A 2019 U.S. study found that 46% of insurers would preferentially cover self-administered aid in dying over possible life-saving treatments, raising ethical concerns about financial incentives influencing end-of-life decisions.